factual
Large pharma deals are transactional and milestone-driven
Large pharma partnerships are typically transactional and milestone-driven with little flexibility, while academic groups find Argenx's collaboration far more exploratory and open.
factualpending
Speaker
JuliaEvidence Quote
“It's very much driven by milestones. There is not so much flexibility.”
Created: 11/17/2026, 3:39:21 AM
Your notes
Loading notes...